MyFinsight
Home
Blog
About
Proceeds from long term
debt, net of issuance...
$96,699K
Proceeds from issuance of
common stock pursuant...
$1,793K
(42.08%↑ Y/Y)
Net cash provided by
financing activities
$1,005K
(-92.85%↓ Y/Y)
Canceled cashflow
$97,487K
Net decrease in
cash, cash...
-$33,606K
(-202.98%↓ Y/Y)
Canceled cashflow
$1,005K
Depreciation and
amortization expense
$6,714K
(-43.43%↓ Y/Y)
Stock-based compensation
expense
$6,342K
(-46.24%↓ Y/Y)
Other
$1,123K
(-19.03%↓ Y/Y)
Accounts payable and
accrued expenses
$602K
(-91.64%↓ Y/Y)
Acquisition of business, net
of cash acquired
-$33,195K
(-200.00%↓ Y/Y)
Proceeds from maturities
of marketable...
$11,975K
(-55.16%↓ Y/Y)
Proceeds from sales of
marketable securities
$1,397K
Proceeds from offerings,
net of issuance...
-$96,998K
(-804.62%↓ Y/Y)
Finance lease principal
payments
$489K
(-57.92%↓ Y/Y)
Net cash (used in)
provided by operating...
-$28,981K
(-240.67%↓ Y/Y)
Net cash used in
investing activities
-$5,630K
(87.70%↑ Y/Y)
Canceled cashflow
$14,781K
Canceled cashflow
$46,567K
Net (loss) income
-$17,740K
(-514.49%↓ Y/Y)
Other assets and
liabilities
$10,896K
(22.51%↑ Y/Y)
Accounts receivable
$6,682K
(-32.43%↓ Y/Y)
something is missing
-$33,195K
Inventory
$5,662K
(303.28%↑ Y/Y)
Change in third party
payor reserves
$2,044K
(140.77%↑ Y/Y)
Deferred tax expense
-$518K
(-356.44%↓ Y/Y)
Change in fair value of
financial liabilities
-$220K
(79.65%↑ Y/Y)
Purchases of property and
equipment and development...
$10,114K
(19.02%↑ Y/Y)
Purchases of marketable
securities
$8,888K
(-71.11%↓ Y/Y)
Back
Back
Cash Flow
GeneDx Holdings Corp. (WGS)
GeneDx Holdings Corp. (WGS)
source: myfinsight.com